Company ProfilePremium

Companion Medical

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Companion Medical - Healthcare showcase

Year Founded & Workforce

2013

200 Employees

Industry

Healthcare

Services

Smart Insulin Pen
C

Companion Medical Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Companion Medical Overview

Company Headquarters: California, US

Founded: 2013

Workforce: ~51-200

Company Working: Companion Medical is a leader in the development of innovative solutions & advanced technology for the management of diabetes. It is the first company to received US Food and Drug Administration (FDA) approval for InPen, a smart insulin pen used to improve diabetes care. The InPen system is consists of a Bluetooth-enabled pen that is connected to an app that offers dose reminders for patients. The company offers its products in the treatment of Type 1 and Type 2 diabetes. The firm has a strong presence in North America and Europe.

Strategy

Companion Medical focuses on increasing its strategic collaborations with leading companies to spreads its network across the globe. Moreover, it acquired organic growth strategies such as expansion & products launch to increase its market share and geographical presence across the globe.

Company Snapshot

200

Employees

2013

Founded

California, US

Headquarters

SWOT Analysis

Strengths

  • Strong research and development capabilities
  • Strong product portfolio
  • Skilled workforce

Weaknesses

  • Lower focus on emerging market

Opportunities

  • Partnerships and collaborations for product line expansion

Threats

  • Rapid technological changes
  • Changing regulatory environment

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
February 2020PartnershipCompanion Medical entered into a partnership with Senseonics Holdings, Inc. (US) to integrate Eversense CGM System real-time glucose data with the InPen smart system that used in insulin delivery.
June 2019CollaborationCompanion Medical entered into a collaboration with DexCom, Inc. (US). This collaboration enables both companies to improve decisions for patients for the management of diabetes treatment.
April 2019ExpansionCompanion Medical expanded its manufacturing & R&D facilities based in San Diego (US). This expansion helped the company to increase its production capacity for smart pens to match the demand in the market.
January 2019Platform LaunchCompanion Medical launched the Android version of its InPen App. This app manages the patient’s insulin doses and provides data for healthcare physicians to make better decisions in the management of diabetes treatment.
July 2018ApprovalCompanion Medical received CE mark approvals for the InPen system. This Approval helped the company to launch & markets its products in the European region.

Product Offering

  • Companion Medical
    • Smart Insulin Pen

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.